Diabetic Macular Edema/Diabetic Retinopathy
Rapid Response From Angiogenesis 2025: Advances in Treating Diabetic Macular Edema
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
Retinal Disease Digest on DME: Opportunities for Optometrists
This activity is supported by independent medical education grants from Regeneron Pharmaceuticals, Inc., and Ocular Therapeutix, Inc.
Clinical Trial Updates in nAMD, DME, RVO, MacTel, and GA Management
This activity is supported by independent medical education grants from Regeneron Pharmaceuticals, Inc.; Genentech, a member of the Roche Group; Neurotech Pharmaceuticals, Inc.; Astellas; EyePoint Pharmaceuticals, Inc.; Opthea Ltd.; Topcon Healthcare, Inc.; Outlook Therapeutics; REGENXBIO Inc.; Ocuphire Pharma; and Carl Zeiss Meditec, Inc.
Taming the Tide: Management of Persistent Retinal Fluid in nAMD and DME
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
Community Practice Connections: Transforming Treatment in nAMD, DME, and DR – Keeping an Eye on Optimal Outcomes
This activity is supported by Regeneron Pharmaceuticals, Inc.
nAMD and DME Management: Game-Changing Sustained Delivery Platforms
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
Extending Dosing Intervals in Retinal Disease: Patient Perspectives and Clinical Insights to Guide Your Practice
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
SimulatED: Pioneering Treat and Extend Therapy – The Impact of Early Application
This activity is supported by an educational grant from MJH Associates, Inc.; Regeneron Healthcare Solutions, Inc.
nAMD and DME: Novel Treatment Plans to Prioritize Real-World Visual Improvements
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
nAMD and DME Management: Exploring Innovative Alternatives to Minimize Injection Frequency
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.